Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasis
Judit Berta, Szilvia Török, Júlia Tárnoki-Zách, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
Zhaoliang Hu, Xushi Zhao, Zhonghua Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Advances in the therapeutic potentials of ligands of the apelin receptor APJ
Gerry T. M. Wagenaar, Gert N. Moll
European Journal of Pharmacology (2025), pp. 177302-177302
Open Access | Times Cited: 1
ANGPTL2 promotes VEGF-A synthesis in human lung cancer and facilitates lymphangiogenesis
Po‐I Liu, Yajing Jiang, An‐Chen Chang, et al.
Aging (2023)
Open Access | Times Cited: 13
Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma
Thomas Williams, Peter N. Nwokoye, Rhoda E. Kuc, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
The Use of Biologics for Targeting GPCRs in Metastatic Cancers
Cian McBrien, David O’Connell
BioTech (2025) Vol. 14, Iss. 1, pp. 7-7
Open Access
Apelin/APJ: Another Player in the Cancer Biology Network
Laura Naldi, Alessandro Peri, Benedetta Fibbi
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2986-2986
Open Access
Exosomal transfer of miR-195-5p restrains lung adenocarcinoma progression
Yongchun Zhou, Gaowei Wang, Jingjing Cai, et al.
Experimental Cell Research (2023) Vol. 424, Iss. 1, pp. 113485-113485
Closed Access | Times Cited: 9
Identification and Characterization of Metastasis‐Initiating Cells in ESCC in a Multi‐Timepoint Pulmonary Metastasis Mouse Model
Ching Ngar Wong, Yu Zhang, Beibei Ru, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 3
Apelin modulates inflammation and leukocyte recruitment in experimental autoimmune encephalomyelitis
Hongryeol Park, Jian Song, Hyun‐Woo Jeong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Roles of apelin/APJ system in cancer: Biomarker, predictor, and emerging therapeutic target
Jiawei Chen, Zhiyue Li, Qun Zhao, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 10, pp. 3734-3751
Closed Access | Times Cited: 13
Melanoma Progression under Obesity: Focus on Adipokines
Joanna Olszańska, Katarzyna Pietraszek‐Gremplewicz, Dorota Nowak
Cancers (2021) Vol. 13, Iss. 9, pp. 2281-2281
Open Access | Times Cited: 18
Apelin-13 Pretreatment Promotes the Cardioprotective Effect of Mesenchymal Stem Cells against Myocardial Infarction by Improving Their Survival
Guona Chen, Xiaoting Liang, Qian Han, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 12
Apelin, a Circulating Biomarker in Cancer Evaluation: A Systematic Review
Christina Grinstead, Saunjoo L. Yoon
Cancers (2022) Vol. 14, Iss. 19, pp. 4656-4656
Open Access | Times Cited: 12
Apelin receptor antagonist boosts dendritic cell vaccine efficacy in controlling angiogenic, metastatic and apoptotic-related factors in 4T1 breast tumor-bearing mice
Javad Masoumi, Nahid Zainodini, Pedram Basirjafar, et al.
Medical Oncology (2023) Vol. 40, Iss. 6
Closed Access | Times Cited: 7
The first report on predictive comparative ligand-based multi-QSAR modeling analysis of 4-pyrimidinone and 2-pyridinone based APJ inhibitors
Suvankar Banerjee, Sandip Kumar Baidya, Balaram Ghosh, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 24, pp. 11591-11607
Closed Access | Times Cited: 10
Loss of apelin blocks the emergence of sprouting angiogenesis in experimental tumors
Abul Kalam Azad, Kieran R. Campbell, Pavel Zhabyeyev, et al.
The FASEB Journal (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 4
Cancer apelin receptor suppresses vascular mimicry in malignant melanoma
Koichi Inukai, Kazuyoshi Kise, Yumiko Hayashi, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 2
Angiopoietin-2 expression and its relationship with lymphangiogenesis and clinicopathological characteristics in cutaneous malignant melanoma
Wei Zheng, Wei Ju, Xihu Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Immunogenic cell death signatures derived from on-treatment tumor specimens for predicting immune checkpoint blockade therapy response and prognosis in metastatic melanoma
Huancheng Zeng, Qiongzhi Jiang, Rendong Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma
Huancheng Zeng, Qiongzhi Jiang, Rendong Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
Bianca Dietsch, Céline Weller, Carsten Sticht, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access
Page 1

Scroll to top